Observational studyJournal of translational medicine2015

HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation.

Eva A H Lanters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.